Replies to post #2237 on Insmed Inc (INSM)

[Christiaan F]

Nothing has changed...Still positive opinion...Review time was referring to the time it took to review...

* Treatment of primary insulin-like growth factor-1 deficiency due to molecular or genetic defects

* Treatment of patients with growth hormone (GH) gene deletion who have developed neutralizing antibodies to GH

CF